The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
dc.contributor.author | Xavier, Joao B. | en |
dc.contributor.author | Young, Vincent B. | en |
dc.contributor.author | Skufca, Joseph | en |
dc.contributor.author | Ginty, Fiona | en |
dc.contributor.author | Testerman, Traci | en |
dc.contributor.author | Pearson, Alexander T. | en |
dc.contributor.author | Macklin, Paul | en |
dc.contributor.author | Mitchell, Amir | en |
dc.contributor.author | Shmulevich, Ilya | en |
dc.contributor.author | Xie, Lei | en |
dc.contributor.author | Caporaso, J. Gregory | en |
dc.contributor.author | Crandall, Keith A. | en |
dc.contributor.author | Simone, Nicole L. | en |
dc.contributor.author | Godoy-Vitorino, Filipa | en |
dc.contributor.author | Griffin, Timothy J. | en |
dc.contributor.author | Whiteson, Katrine L. | en |
dc.contributor.author | Gustafson, Heather H. | en |
dc.contributor.author | Slade, Daniel J. | en |
dc.contributor.author | Schmidt, Thomas M. | en |
dc.contributor.author | Walther-Antonio, Marina RS S. | en |
dc.contributor.author | Korem, Tal | en |
dc.contributor.author | Webb-Robertson, Bobbie-Jo M. | en |
dc.contributor.author | Styczynski, Mark P. | en |
dc.contributor.author | Johnson, W. Evan | en |
dc.contributor.author | Jobin, Christian | en |
dc.contributor.author | Ridlon, Jason M. | en |
dc.contributor.author | Koh, Andrew Y. | en |
dc.contributor.author | Yu, Michael | en |
dc.contributor.author | Kelly, Libusha | en |
dc.contributor.author | Wargo, Jennifer A. | en |
dc.contributor.department | Biochemistry | en |
dc.date.accessioned | 2021-09-27T15:00:46Z | en |
dc.date.available | 2021-09-27T15:00:46Z | en |
dc.date.issued | 2020-03-01 | en |
dc.date.updated | 2021-09-27T15:00:42Z | en |
dc.description.abstract | The collection of microbes that live in and on the human body – the human microbiome – can impact on cancer initiation, progression, and response to therapy, including cancer immunotherapy. The mechanisms by which microbiomes impact on cancers can yield new diagnostics and treatments, but much remains unknown. The interactions between microbes, diet, host factors, drugs, and cell–cell interactions within the cancer itself likely involve intricate feedbacks, and no single component can explain all the behavior of the system. Understanding the role of host-associated microbial communities in cancer systems will require a multidisciplinary approach combining microbial ecology, immunology, cancer cell biology, and computational biology – a systems biology approach. | en |
dc.description.version | Published version | en |
dc.format.extent | Pages 192-204 | en |
dc.format.extent | 13 page(s) | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.1016/j.trecan.2020.01.004 | en |
dc.identifier.eissn | 2405-8033 | en |
dc.identifier.issn | 2405-8025 | en |
dc.identifier.issue | 3 | en |
dc.identifier.orcid | Slade, Daniel [0000-0001-5634-7220] | en |
dc.identifier.other | S2405-8033(20)30017-0 (PII) | en |
dc.identifier.pmid | 32101723 | en |
dc.identifier.uri | http://hdl.handle.net/10919/105085 | en |
dc.identifier.volume | 6 | en |
dc.language.iso | en | en |
dc.publisher | Cell Press | en |
dc.relation.uri | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000517798700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=930d57c9ac61a043676db62af60056c1 | en |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
dc.subject | Life Sciences & Biomedicine | en |
dc.subject | Oncology | en |
dc.subject | HUMAN GUT MICROBIOTA | en |
dc.subject | SPATIAL-ORGANIZATION | en |
dc.subject | HELICOBACTER-PYLORI | en |
dc.subject | METABOLISM | en |
dc.subject | EFFICACY | en |
dc.subject | THERAPY | en |
dc.subject | RISK | en |
dc.subject | PERSISTENCE | en |
dc.subject | RESISTANCE | en |
dc.subject | IPILIMUMAB | en |
dc.subject | 1112 Oncology and Carcinogenesis | en |
dc.subject.mesh | Central Nervous System | en |
dc.subject.mesh | Animals | en |
dc.subject.mesh | Humans | en |
dc.subject.mesh | Mice | en |
dc.subject.mesh | Bacteria | en |
dc.subject.mesh | Oncogenic Viruses | en |
dc.subject.mesh | Helicobacter Infections | en |
dc.subject.mesh | Tumor Virus Infections | en |
dc.subject.mesh | Neoplasms | en |
dc.subject.mesh | Stomach Neoplasms | en |
dc.subject.mesh | Gastritis | en |
dc.subject.mesh | Analgesics, Opioid | en |
dc.subject.mesh | Immunotherapy | en |
dc.subject.mesh | Environmental Microbiology | en |
dc.subject.mesh | Symbiosis | en |
dc.subject.mesh | Drug Synergism | en |
dc.subject.mesh | Probiotics | en |
dc.subject.mesh | Host-Pathogen Interactions | en |
dc.subject.mesh | Microbiota | en |
dc.subject.mesh | Gastrointestinal Microbiome | en |
dc.title | The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View | en |
dc.title.serial | Trends in Cancer | en |
dc.type | Article | en |
dc.type.dcmitype | Text | en |
dc.type.other | Journal | en |
dcterms.dateAccepted | 2020-01-06 | en |
pubs.organisational-group | /Virginia Tech | en |
pubs.organisational-group | /Virginia Tech/Agriculture & Life Sciences | en |
pubs.organisational-group | /Virginia Tech/Agriculture & Life Sciences/Biochemistry | en |
pubs.organisational-group | /Virginia Tech/Faculty of Health Sciences | en |
pubs.organisational-group | /Virginia Tech/All T&R Faculty | en |
pubs.organisational-group | /Virginia Tech/Agriculture & Life Sciences/CALS T&R Faculty | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- The Cancer Microbiome Distinguishing Direct and Indirect Effects Requires a Systemic View.pdf
- Size:
- 1.47 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version